Lorient Capital

Behavior Frontiers was founded in 2004 by CEO Helen Mader to provide autism care across age groups, with an emphasis on early intervention for children ages 3 to 6.

In 2022, Lorient closed two platform investments and one recapitalization, with over $100 million in equity co-investment alongside Fund II commitments. Since 2018, it completed seven platform investments, over 30 acquisitions, and five exits/recapitalizations.

Stephanie DeGennaro will oversee Lorient’s legal strategy as general counsel. She joins from McDermott Will & Emery, where she was a partner advising healthcare providers and private equity sponsors on transactions.

Eric was a vice president at Comvest Partners, focused on consumer and e-commerce investments, and a hedge fund analyst at Moore Capital Management. He holds a BA from University of Miami and is a CFA charterholder.

David co-founded Lorient Capital, a healthcare-focused lower middle market private equity firm, and leads its investment strategy, business development, and organizational growth.

John works with portfolio companies on support services and operational infrastructure. He has a decade of healthcare leadership experience and holds an MBA from the University of Michigan.

Karolien provides administrative support to Lorient’s Managing Partners and oversees the administration of the Miami office. She previously worked in administrative roles in venture capital and consulting in the U.S. and Europe. She holds a BA in Project Management.

Lisa leads data strategy across Lorient’s portfolio and has more than 20 years of experience, most recently as senior enterprise data architect at Rocket Companies.

Shared expectations that keep teams aligned

Follow Lorient on LinkedIn for the latest updates, insights, and portfolio news.

Growth can create drift. Expectations can split, information may muddy, and performance can become uneven. Lorient strives to bring companies back into alignment with the structure and operating rhythm that make daily execution consistent and scale achievable.